Alliance to drive greater efficiencies in oncology and hematology clinical trials BOSTON and OSAKA, August 21, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global provider of biopharmaceutical services, and the Osaka International...
Read More
4 Minutes